HOME >> BIOLOGY >> NEWS
Embryo project investigates agents of change in science

TEMPE, Ariz. -- An ambitious group of historians, philosophers, bioethicists, scientists, lawyers and policy experts from ASU will be taking a detailed look at the history of embryo research in order to understand how society, culture and technology have affected the course of science.

ASU professor Jane Maienschein and her colleagues have been awarded a three-year grant of $750,000 by the National Science Foundation for the project as a part of the NSF Human and Social Dynamics program.

Maienschein, director of ASU's Center for Biology and Society, will lead a diverse group of researchers in examining how the study of embryos has developed, especially from the 19th century to the present. Research leaders in the project are all members of ASU's School of Life Sciences and include professors Manfred Laubichler; Gary Marchant, director of the Center for Law, Science and Technology; and Daniel Sarewitz, director of the Consortium for Science, Policy and Outcomes.

Under the "embryo project," Maienschein and her ASU collaborators have assembled a group of undergraduate and graduate researchers, who will work with two dozen investigators from six countries to examine the different scientific, social, cultural and organizational contexts that have affected the development of embryology as a science.

"Embryo research serves as an ideal candidate to investigate the intersection of biology and society," Maienschein said. Stem cell research, a recent development in the study of embryos, provides a good example of how ethical, legal, political and religious factors can affect science and its role in society.

Goals for the project include providing a rich description of embryo research over key periods of its history, analyzing and comparing each period for agents of change and "developing materials for scholars and the general public to address any questions related to embryo research," Maienschein said.

In
'"/>

Contact: Skip Derra
skip.derra@asu.edu
480-965-4823
Arizona State University
18-Oct-2006


Page: 1 2

Related biology news :

1. Embryonic selection of sex avoids conceiving blind children
2. Embryonic stem cells do better on bumpy nanoscale mattress
3. Embryonic patterning makes the feathers fly
4. Embryo fossils reveal animal complexity 10 million years before Cambrian Explosion
5. Embryo tests give parents the choice
6. AAAS urges US President to sign Embryonic Stem Cell Act
7. Embryos exposed in 3-D
8. Embryos tell story of Earths earliest animals
9. Embryonic stem cells accrue genetic changes
10. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
11. Embryonic law and order

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Embryo project investigates agents change science

(Date:10/22/2014)... (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended September 30, 2014. Revenue for the ... 40% compared to $4.3 million in the same quarter last ... $4.1 million compared to $1.0 million in the third quarter ... period was primarily due to: i) a $1.0 million increase ...
(Date:10/18/2014)... stress and stress-related psychiatric disorders are associated ... the molecular mechanisms underlying this relation are ... the development of targeted preventive strategies and ... diseases. This work is presented at the ... Now an international group of researchers from ...
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Researchers find why depression and aging linked to increased disease risk 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
(Date:10/25/2014)... 2014 Today, Nerium International, a leader ... of its “Reflect Your Youth” contest, an effort launched ... a difference in their skin since using Nerium’s product ... on life as a result of their newfound confidence. ... effort by Nerium International to inspire conversations focused on ...
(Date:10/25/2014)... , October 24, 2014 Oramed ... pharmaceutical company focused on the development of oral drug ... Nadav Kidron will present at FireRock Capital,s Micro-Cap ... Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ,Time: ... New York City , ...
(Date:10/25/2014)... 24, 2014 Research and Markets ... by Product , Research Area & by End User ... offering. In this report, the global ... research areas, and end users. The product segments of ... instruments & consumables, kits, and reagents. The subsegments of ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis plc ... pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced ... acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., which ... the treatment of diabetic gastroparesis and other GI functional ... Phase 2 trial of relamorelin for the treatment of ...
Breaking Biology Technology:Nerium International™ Inspires Conversation About the Journey of Aging with “Reflect Your Youth” Contest 2Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 2Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5
Cached News: